Most Recent
The High Court has unanimously granted home retailer Bed Bath N’ Table’s appeal of a ruling that retailer House did not engage in misleading and deceptive conduct in setting up its Bed & Bath stores.
A patent holding company is challenging the dismissal of its infringement case over Apple's Touch ID and Face ID technology.
Apple has defeated a claim by an Australian non-practicing entity that its patents for a remote entry system were infringed by the tech company’s Touch ID and Face ID technology.
The High Court will weigh in on the relevance of reputation in passing off claims, taking up an appeal by Bed Bath N’ Table of a finding that rival retailer House did not engage in misleading and deceptive conduct in setting up its Bed & Bath stores.
An appeal by a family-owned Adelaide deli in a trade mark fight with an Italian food hall in Melbourne has fallen flat.
Home retailer Bed Bath N’ Table has asked the High Court to reverse a Full Court judgment that found retailer House did not engage in misleading and deceptive conduct in setting up its Bed & Bath stores.
A "time poor" judge's extensive copying and pasting of submissions and an offensive tweet by senator Pauline Hanson were at the centre of the week's biggest litigation wins.
In a loss for Bed Bath N' Table, the Full Court has overturned a finding that homewares retailer House engaged in misleading and deceptive conduct by setting up its 'Bed & Bath' stores.
A judge has rejected Samsung Bioepis' bid to discover research and development documents from Pfizer as it seeks to invalidate the drug giant's patent for its blockbuster autoimmune drug Enbrel, agreeing with Pfizer that it may be "no more than an exercise in fishing".
Drug giant Pfizer has blasted Samsung Bioepis' “fishing expedition” in its suit alleging infringement of the patent for its blockbuster arthritis drug Enbrel, telling the court the Korean biotech should not be allowed to dig for new grounds of invalidity.